Search company, investor...
Search

Predict your next investment

Private Equity
sinopharmcapital.com

See what CB Insights has to offer

Investments

73

Portfolio Exits

8

Funds

5

Partners & Customers

1

About Sinopharm Capital

Sinopharm Capital, under Sinopharm Group, is a professional PE company specialized in medical and healthcare industry. The funds are managed by a team of Sinopharm Group senior management team members, investment bank experts and professional investors, who has profound understanding about development and operation of Chinese medical and healthcare industry and rich knowledge of capital operation. We have the capability to efficiently integrate both internal and external Sinopharm Group resources, industry resources and capital strengths.

Sinopharm Capital Headquarters Location

16/F No.266 Hankou Road

Shanghai, Shanghai, 200001,

China

86-21-63337900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Sinopharm Capital News

DealShot: 23 Deals Worth $475 Million Including Sinopharm Capital, Eastern Bell And Others

Mar 31, 2022

All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed. Posting....

Sinopharm Capital Investments

73 Investments

Sinopharm Capital has made 73 investments. Their latest investment was in Origiencell as part of their Series B on August 8, 2022.

CBI Logo

Sinopharm Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/1/2022

Series B

Origiencell

$120M

Yes

1

6/29/2022

Series A

AstraBio

$14.93M

Yes

3

3/31/2022

Seed VC

Metanovas

$10M

Yes

2

3/31/2022

Seed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

3/28/2022

Seed VC - II

Subscribe to see more

Subscribe to see more

10

Date

8/1/2022

6/29/2022

3/31/2022

3/31/2022

3/28/2022

Round

Series B

Series A

Seed VC

Seed VC - III

Seed VC - II

Company

Origiencell

AstraBio

Metanovas

Subscribe to see more

Subscribe to see more

Amount

$120M

$14.93M

$10M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

3

2

10

10

Sinopharm Capital Portfolio Exits

8 Portfolio Exits

Sinopharm Capital has 8 portfolio exits. Their latest portfolio exit was InventisBio on July 25, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/25/2022

IPO

$99M

Public

1

7/25/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

10/13/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/18/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

5/17/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/25/2022

7/25/2022

10/13/2021

6/18/2021

5/17/2021

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Sinopharm Capital Fund History

5 Fund Histories

Sinopharm Capital has 5 funds, including Sino-Singapore Healthcare Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/21/2019

Sino-Singapore Healthcare Fund

$150M

1

Sinopharm Medical Device Equity Investment Fund

0

Shanghai Sinopharm Equity Investment Fund Partners

Subscribe to see more

Subscribe to see more

10

Sinopharm Healthcare Fund LP

Subscribe to see more

Subscribe to see more

10

Shanghai Sinopharm Medical Equiptments Equity Investment Fund LP

Subscribe to see more

Subscribe to see more

10

Closing Date

6/21/2019

Fund

Sino-Singapore Healthcare Fund

Sinopharm Medical Device Equity Investment Fund

Shanghai Sinopharm Equity Investment Fund Partners

Sinopharm Healthcare Fund LP

Shanghai Sinopharm Medical Equiptments Equity Investment Fund LP

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$150M

Sources

1

0

10

10

10

Sinopharm Capital Partners & Customers

1 Partners and customers

Sinopharm Capital has 1 strategic partners and customers. Sinopharm Capital recently partnered with Novena Global Lifecare on June 6, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

6/24/2019

Partner

Singapore

Novena Global Lifecare strikes strategic partnership with Sinopharm Capital and Cedarlake Capital to expand Asia footprint and create US$150 million SinoSingapore Healthcare Fund

Mr. Bao Yi , Founder and Chairman of Cedarlake Capital , said : `` We are delighted to partner Sinopharm Capital in its strategic investment in the Sino-Singapore Healthcare Fund and Novena Global Lifecare as we believe there is an immense opportunity to create win-win cross-border opportunities .

1

Date

6/24/2019

Type

Partner

Business Partner

Country

Singapore

News Snippet

Novena Global Lifecare strikes strategic partnership with Sinopharm Capital and Cedarlake Capital to expand Asia footprint and create US$150 million SinoSingapore Healthcare Fund

Mr. Bao Yi , Founder and Chairman of Cedarlake Capital , said : `` We are delighted to partner Sinopharm Capital in its strategic investment in the Sino-Singapore Healthcare Fund and Novena Global Lifecare as we believe there is an immense opportunity to create win-win cross-border opportunities .

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.